Literature DB >> 6802289

Priorities for immunisation against hepatitis B.

A J Zuckerman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 6802289      PMCID： PMC1496681          DOI： 10.1136/bmj.284.6317.686

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN： 0267-0623


× No keyword cloud information.
  22 in total

1.  Chemically synthesized peptides predicted from the nucleotide sequence of the hepatitis B virus genome elicit antibodies reactive with the native envelope protein of Dane particles.

Authors:  R A Lerner; N Green; H Alexander; F T Liu; J G Sutcliffe; T M Shinnick
Journal:  Proc Natl Acad Sci U S A       Date:  1981-06       Impact factor: 11.205

2.  Antibody to hepatitis B surface antigen after a single inoculation of uncoupled synthetic HBsAg peptides.

Authors:  G R Dreesman; Y Sanchez; I Ionescu-Matiu; J T Sparrow; H R Six; D L Peterson; F B Hollinger; J L Melnick
Journal:  Nature       Date:  1982-01-14       Impact factor: 49.962

3.  A synthetic peptide with hepatitis B surface antigen reactivity.

Authors:  T P Hopp
Journal:  Mol Immunol       Date:  1981-09       Impact factor: 4.407

4.  Viral hepatitis: report on WHO informal consultation.

Authors:  R W McCollum; A J Zuckerman
Journal:  J Med Virol       Date:  1981       Impact factor: 2.327

5.  Synthesis of hepatitis B surface and core antigens in E. coli.

Authors:  J C Edman; R A Hallewell; P Valenzuela; H M Goodman; W J Rutter
Journal:  Nature       Date:  1981-06-11       Impact factor: 49.962

6.  Developing synthetic vaccines.

Authors:  A J Zuckerman
Journal:  Nature       Date:  1982-01-14       Impact factor: 49.962

7.  Immunogenic effect of inactivated hepatitis B vaccine: comparison of 20 microgram and 40 microgram doses.

Authors:  S Krugman; H P Holley; M Davidson; M S Simberkoff; N Matsaniotis
Journal:  J Med Virol       Date:  1981       Impact factor: 2.327

8.  The immune response of healthy adults to a reduced dose of hepatitis B vaccine.

Authors:  W Szmuness; C E Stevens; E J Harley; E A Zang; P E Taylor; H J Alter
Journal:  J Med Virol       Date:  1981       Impact factor: 2.327

9.  Immunization of chimpanzees with hepatitis B virus-derived polypeptides.

Authors:  G R Dreesman; F B Hollinger; Y Sanchez; P Oefinger; J L Melnick
Journal:  Infect Immun       Date:  1981-04       Impact factor: 3.441

10.  A controlled clinical trial of the efficacy of the hepatitis B vaccine (Heptavax B): a final report.

Authors:  W Szmuness; C E Stevens; E A Zang; E J Harley; A Kellner
Journal:  Hepatology       Date:  1981 Sep-Oct       Impact factor: 17.425
View more
  5 in total

1.  Time for action on hepatitis B immunisation.

Authors:  R G Finch
Journal:  Br Med J (Clin Res Ed)       Date:  1987-01-24

2.  Blood donors with a history of jaundice.

Authors:  P M Jones
Journal:  Br Med J (Clin Res Ed)       Date:  1982-09-25

3.  Hepatitis B, tropical ulcers, and immunisation strategy in Kiribati.

Authors:  C J Tibbs
Journal:  Br Med J (Clin Res Ed)       Date:  1987-02-28

4.  Hepatitis B vaccine requirements in at-risk hospital personnel: a survey of hospitals in Metropolitan Toronto.

Authors:  R A Coates; J Rankin; M L Halliday
Journal:  Can Med Assoc J       Date:  1983-03-01       Impact factor: 8.262

5.  Hepatitis B follow-up among Indochinese refugees.

Authors:  E S Nicholls; R K Chaudhary; D A Kennedy; J Jung; J W Davies; P Gill
Journal:  Can Med Assoc J       Date:  1984-11-01       Impact factor: 8.262
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.